According to Voyager Therapeutics 's latest financial reports the company's current revenue (TTM) is $0.25 B. In 2022 the company made a revenue of $40.9 M an increase over the years 2021 revenue that were of $37.41 M.The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.
Year | Revenue | Change |
---|---|---|
2023 (TTM) | $0.25 B | 511.18% |
2022 | $40.9 M | 9.34% |
2021 | $37.41 M | -78.14% |
2020 | $0.17 B | 63.93% |
2019 | $0.10 B | 1270.14% |
2018 | $7.61 M | -24.82% |
2017 | $10.13 M | -28.73% |
2016 | $14.22 M | -17.96% |
2015 | $17.33 M |
Company | Revenue | Revenue differencediff. | Country |
---|---|---|---|
ORIC Pharmaceuticals
ORIC | N/A | N/A | ๐บ๐ธ USA |